Protein Degradation Leader Nurix Prepares First Clinical Trial

Company Claims Unique Protein Modulation Potential

 
• By Andrew McConaghie
San Francisco, California, USA Noe Valley skyline.
Following a successful IPO, San-Francisco-based Nurix is preparing its protein degradation inhibitor for clinical trials.

More from Business

More from Scrip